US Patent Issued to REGENERON PHARMACEUTICALS on July 29 for "Methods of treatment using a leptin receptor agonist antibody" (New York, New Jersey Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,503, issued on July 29, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Methods of treatment using a leptin receptor agonist antibody" was invented by Jesper Gromada (Scarsdale, N.Y.), Panayiotis Stevis (West Orange, N.J.), Judith Altarejos (Chappaqua, N.Y.) and Andrew J. Murphy (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are therapeutic methods of treatment using agonist leptin receptor (LEPR) antibodies, antigen-binding fragments thereof, or compositions comprising the LEPR antibodies or antigen-binding fragments thereof. Such therapeutic methods include treatment for conditions related...